Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04597619 · ClinicalTrials.gov registry record · NA

Evaluation of a Nonopioid Recovery Pathway Following Surgery for Kidney Stones

A NA study, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT04597619 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04597619, a NA study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Evaluation of a nonopioid recovery pathway after percutaneous nephrolithotomy is a pragmatic pilot study that will apply the knowledge and experience gained with development of an outpatient opioid reduction protocol to percutaneous nephrolithotomy (PCNL). We have previously demonstrated that outpatient ureteroscopy and stent placement without postoperative opioid prescriptions is possible in the vast majority of patients. The success of this is dependent upon a multimodal approach to the patient's experience of undergoing endoscopic kidney stone surgery (ureteroscopy) and focuses on the preoperative, perioperative, and postoperative stages of intervention. Our hypothesis is that a novel nonopioid pathway after PCNL is both feasible and safe and will reduce postoperative prescriptions for opioids without impacting clinical outcomes, patient satisfaction or outpatient resources.

Interventions

  • OTHER Novel Nonopioid Pathway

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-12-01
Est. Completion 2022-06-11
Phase NA

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT04597619

The ClinicalTrials.gov registry entry for NCT04597619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Novel Nonopioid Pathway is the first listed.

NCT04597619 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04597619 about?

NCT04597619 is a clinical study titled "Evaluation of a Nonopioid Recovery Pathway Following Surgery for Kidney Stones". Evaluation of a nonopioid recovery pathway after percutaneous nephrolithotomy is a pragmatic pilot study that will apply the knowledge and experience gained with development of an outpatient opioid reduction protocol to percutaneous nephrolithotomy (PCNL). We have previously demonstrated that outpat...

What is the current status of trial NCT04597619?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-12-01. Estimated completion is 2022-06-11.

What interventions are being tested in trial NCT04597619?

The interventions under investigation include: Novel Nonopioid Pathway (OTHER).

Who is sponsoring clinical trial NCT04597619?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.